ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166237; 2) Community: the network communities that were significantly associated with the response to NSC 166237; 3) Molecule: the relationships between components within communities and NSC 166237; 4) MDR: the compounds that were significantly associated with the NSC 166237.

NSC Compound Enrichment Correlation
NSC 355461 B621099K443 0.045446901295916 0.25063288
NSC 58906 9H-Purine, 6-[(o-chlorobenzyl)thio]-9-(2-chloroethyl)- (8CI) 0.045446901295916 0.21796915
NSC 606498 Camptothecin Derivative 0.045446901295916 0.43776323
NSC 609699 Topotecan hydrochloride 0.045446901295916 0.55112035
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.045446901295916 0.074279401
NSC 644960 Null 0.045446901295916 0.41908947
NSC 653860 Null 0.045446901295916 0.48598769
NSC 662123 Null 0.045446901295916 0.07918443
NSC 664314 Null 0.045446901295916 0.53139024
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.045446901295916 0.59652644
Total:64  Current:54    [First] [Prev] [Next] [Last]